A comparison of the efficacy and tolerability of the PCSK9...

Atherosclerosis 2017 / 08 Vol. 263

A comparison of the efficacy and tolerability of the PCSK9 inhibitors, Alirocumab and evolocumab, in routine lipid clinic practice

Jones, Alan, Peers, Kate, Ramachandran, Sud, Syed, Ateeq
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
263
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2017.06.802
Date:
August, 2017
File:
PDF, 114 KB
english, 2017
Conversion to is in progress
Conversion to is failed